Target intelligence / Profile preview

Cardiac extracellular matrix (with associated cardiac cells) (ECM (for extracellular matrix); cardiac cells are not abbreviated as a target)

Target
ECM (for extracellular matrix); cardiac cells are not abbreviated as a target
Molecular classification
Other
01

Overview

The cardiac extracellular matrix is a dynamic, 3-dimensional network of macromolecules (e.g., collagens, laminins, fibronectin, proteoglycans) that provides both structural and regulatory support to cardiac cells. This system governs tissue architecture, cell adhesion, migration, and survival, and actively participates in tissue regeneration, fibrosis, and pathological remodeling during cardiovascular disease. Cardiac cells—primarily cardiomyocytes, fibroblasts, endothelial cells, and smooth muscle cells—produce and respond to signals from the extracellular matrix through receptors such as integrins, resulting in feedback loops that shape heart health and disease processes[1][2][3]. The ECM and its interactions with cardiac cells are crucial in development, homeostasis, and adaptation to injury, but are not a singular molecular target.

Other names
Heart matrixcardiac ECMmyocardial ECMheart cells (cardiomyocytes, cardiac fibroblasts, etc.)
02

Mechanism of action

Inhibition of ECM remodeling (e.g., reduction of fibrosis); Modulation of cell-matrix interactions (e.g., via integrins, MMPs)

03

Biological functions

Structural support and architectureRegulation of cell adhesion, migration, proliferation, differentiation, and deathSignal transduction via integrins and other receptorsTissue repair and regenerationRemodeling under pathologic conditions
04

Disease associations

Cardiovascular disease (especially fibrosis and heart failure)Tissue regeneration and injury responseAging-related functional decline
05

Safety considerations

Risk of impaired healing and tissue integrity if ECM is excessively disruptedOff-target effects involving non-cardiac ECM or non-cardiac cellsDifficulty distinguishing beneficial vs. maladaptive remodeling
06

Interacting drugs

Antifibrotic agents (experimental and in development)

3 more in the full profile.

07

Biomarkers

ECM protein levels (collagen I/III, fibronectin, laminins)circulating matrikinescardiac fibroblast activityimaging of fibrosis

Beyond the preview

Go deeper on Cardiac extracellular matrix (with associated cardiac cells) (ECM (for extracellular matrix); cardiac cells are not abbreviated as a target).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiac extracellular matrix (with associated cardiac cells) (ECM (for extracellular matrix); cardiac cells are not abbreviated as a target).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call